Pharmacological Evaluation and Phytochemical Screening of Dactylorhiza Hatagirea on Anti –Ulcer Activity
Keywords:
Peptic Ulcer, Dactylorhiza hatagirea, Asprin Induced Ulcer, H. pylori, Hydroalcoholic ExtractAbstract
In the present work, the acute toxicity carried out based on OECD-423 rules for chloroform extract of Dactylorhiza hatagirea prove that, the doses of 250 and 400 mg/kg did not indication any sign of toxicity and mortality. Hence these doses of the concentrate were chosen for assessment of anti-ulcer activity. Dactylorhiza hatagirea in the highest dose tested (400 mg/kg), shows increased in Gastric pH and Gastric juice pH, whereas decrease in Gastric content, Gastric juice volume and Total acidity. Therefore, as per histopathological evaluation studies, it was concluded that, Dactylorhiza hatagirea, at the highest dose of 400 mg/kg, found to be safe and more effective in eradicating gastric ulceration. In Conclusion, based on the results obtained the chloroform extract of Dactylorhiza hatagirea treated groups demonstrates a critical impact when contrasted with control group animals which showing that the plant having the having the anti- ulcer activity. The antiulcer action of Dactylorhiza hatagirea was assessed by pylorus ligation instigated ulcer models. These models cause the gastric ulcer in people. Numerous variables and instruments are associated with the ulcerogensis and gastric mucosal harm. Pylorus ligation induced ulcer was utilized to note the impact of Dactylorhiza hatagirea extract on gastric acid secretion and bodily fluid emission. The ligature of the opening finish of the abdomen causes accumulation of internal organ acid within the abdomen. This increase within the internal organ acid secretion causes ulcers within the abdomen. Ligation of pyloric end of the stomach is made in 24 h fasted rats; the UI is resolved 4 h after pylorus ligation. The lesions created by this methodology are placed inside the lumen area of abdomen.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2025 International Journal of Biomedical and Advance Research

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).